Valneva Completes EUR 45 Million Capital Increase

CompaniesHealth Care ♦ Published: February 4, 2015; 16:00 ♦ (Vindobona)

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

Valneva Completes EUR 45 Million Capital Increase / Picture: © Valneva SE

The final gross proceeds of the Rights Issue amount to EUR 45,031,721.02, corresponding to the issuance of 18,231,466 new ordinary shares, at a subscription price of EUR 2.47 per new ordinary share.

Total subscription orders for the Rights Issue amounted to approximately EUR 81.1 million, i.e. a subscription rate of approximately 180.0%.

• 17,272,706 new…